Hyliion holder plans sale of 15,000 shares
Hyliion Holdings Corp. (HYLN) is the issuer for a planned resale of its common stock under Rule 144.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Hyliion Holdings Corp. (HYLN) is the issuer for a planned resale of its common stock under Rule 144. UBS Financial Services Inc., as broker, has filed on behalf of Jose Oxholm for the potential sale of up to 15,000 shares of Hyliion common stock on the NYSE around 08/21/2026. The notice also reports that 30,000 shares of common stock were acquired for cash on 08/20/2026 in connection with an employee benefit arrangement.
Key Figures
Key Terms
Rule 144 regulatory
attorney-in-fact regulatory
Employee Benefit financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Form 144 filing disclose for HYLN?
Who is the selling security holder in this Hyliion (HYLN) Form 144?
AI-generated analysis. How Rhea-AI works. Not financial advice.